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Objective: We investigated the outcomes of hybrid repair of thoracoabdominal aortic aneurysms and performed meta-
analyses and meta-regressions to assess whether the number of stages during hybrid repair is associated with mortality.
Methods: Review methods were according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis
(PRISMA) guidelines. The primary outcome was 30-day mortality. Secondary outcomes of procedural and clinical
success were reported descriptively. Meta-analyses, meta-regressions, and logistic regressions were performed to estimate
the odds ratio (OR) describing the association between the staging of the operation and in-hospital death.
Results: We included 19 studies of 660 patients. Procedures were single-staged in 288 patients and staged in 372.
Perioperative mortality ranged from 0% to 44.4%, and spinal cord ischemia ranged from 0% to 15.3%. After a mean follow-
up of 26months (range, 6-88.5months), the overall mortality was 20.8%. Themeta-regression of all studies’ summary data
(OR, 0.64; 95% conﬁdence interval [CI], 0.19-2.16; P[ .45; I2[ 0.42) and a meta-regression where mortality rates in
four studies were stratiﬁed by operative staging (OR, 0.57; 95% CI, 0.24-1.36; P[ .19; I2[ 0.38) supported a two-stage
procedure but failed to reach statistical signiﬁcance. Logistic regressions of individual patient data from a single center
demonstrated evidence that a staged procedure was safer (adjusted OR, 0.04; 95% CI, 0.00-0.96; P < .05).
Conclusions: Hybrid repair of thoracoabdominal aortic aneurysms may reduce early morbidity and mortality even in
a group considered high risk for open surgery but still carries risks of perioperative complications. This study suggested
advantages to a staged procedure, but statistically signiﬁcant evidence is lacking. Prospective data are still needed to
optimize hybrid repair and best deﬁne its role. (J Vasc Surg 2013;58:1192-200.)Thoracoabdominal aortic aneurysm (TAAA) repair is
a formidable challenge. Various surgical techniques have
been adopted, but perioperative complications remain
substantial. The development of catheter-based interven-
tions, such as endovascular aortic repair, has heralded
a paradigm shift in the treatment of vascular disorders,
but totally endovascular repair of thoracoabdominal aneu-
rysms is not applicable to all patients due to morphologic
constraints.
Hybrid operations combine extra-anatomic debranch-
ing of the visceral vessels with staged or immediate endo-
vascular aortic relining using aortic stent grafts. The
absence of a thoracotomy and single-lung ventilation are
seen as advantages in patients with respiratory compromise,
and the lack of aortic cross-clamping with sequential
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2allows patients with reduced cardiac reserve to remain
hemodynamically stable, limiting the physiologic derange-
ments associated with the traditional surgical approach.
One of the unanswered questions relating to hybrid aneu-
rysm repairs is whether to operate as a single procedure or
a two-stage procedure. One view is that a patient who has
undergone extensive intra-abdominal dissection should not
immediately undergo stent grafting due to an increased risk
of perioperative complications associated with contrast use
and prolongation of the procedure. In contrast, the main
theoretical drawback of staged repair is the risk of interval
rupture.1
A number of individual studies have reported the
results of hybrid TAAA repair, but controversy persists
regarding technique. The aim of this study was to provide
a systematic review of hybrid repair for TAAAs, with partic-
ular reference to any difference in results between single
and staged procedures.
METHODS
Search strategy. A literature search was undertaken to
identify all published studies in the past 15 years reporting
hybrid repair for TAAA. Candidate studies in English were
sought through a computerized search of MEDLINE
(National Library of Medicine, Bethesda, Md) databases
for the period 1950 to September 2012. Key words entered
in this search were “thoracic,” “abdominal,” “thoracoab-
dominal,” “aortic aneurysm,” “endovascular,” “stent-
graft,” “endograft,” “visceral bypass graft,” “visceral
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The reference lists of all relevant retrieved articles were eval-
uated manually to augment the initial literature search.
Study selection. Studies were considered for inclusion
and further review on the basis of these criteria:
d Reporting hybrid repair for management of TAAA;
d Including at least 5 patients treated with this method;
d Reporting clinical outcome.
Studies containing duplicate data were excluded.
Studies with the most recent or the best-documented
material from the same authors were used for analysis.
Data extraction. Two independent analysts (M.C.,
L.C.) extracted data for 30-day and midterm mortality,
demographics, comorbidity, case selection (Crawford
classiﬁcation, elective or emergent patients), operative
details, procedural success (deﬁned by technically success-
ful deployment of the endoprosthesis at the intended target
location and completed visceral debranching), and early
(<30-day morbidity and mortality) and midterm (>30-day
morbidity and mortality) outcomes (endoleak, stroke,
paraparesis or paraplegia, renal failure, bowel ischemia,
severe cardiopulmonary complications, freedom from
reintervention). Study quality was rated according to
a formal assessment check list.2
Primary and secondary outcomes. The primary out-
come measure was deﬁned as 30-day mortality. In studies
reporting only in-hospital mortality, 30-day mortality was
determined through reference to the reported date of
death. Deaths due to the rupture of an aortic aneurysm
after the ﬁrst stage of the hybrid procedure were included
in the 30-day mortality of the staged procedure group.
Secondary outcomes were classiﬁed as perioperative
(technical success, endoleak, stroke, spinal cord ischemia,
renal failure) or postoperative (postoperative complica-
tions, hospital length of stay) events.
Individual patient data from St George’s Vascular
Institute. A single-center experience of consecutive hybrid
procedures for the management of thoracoabdominal
aneurysm was reviewed during a 7-year period from 2005
to 2011 to update previously published results.3 Technical
and operative details were as previously published.4
Patients who underwent a hybrid repair as a one-stage or
two-stage procedure with a follow-up duration of at least
6 months were included. Data were obtained from the case
notes, electronic patient records, and the Picture Archiving
and Communicating System, and entered into a dedicated
database, including demographic, physiologic, pathologic,
anatomic, and outcome data. The primary outcome
measure was 30-day mortality.
Statistical analysis. The primary outcome (30-day
mortality) was subject to meta-regression and meta-
analysis, with a focus on comparing one-stage with
two-stage procedures. All analyses used nonrandomized
data and sowere subject to concerns involving observational
data. In particular, this included confounding factors, and
so, to the extent permitted by the available data, statisticaladjustment was performed for potential confounders
in regression models. Four statistical analyses were
undertaken:
Analysis 1. Meta-regression of one-stage vs two-stage
repair using aggregate-level data from all studies. A stan-
dard meta-regression was performed where the empiric log
odds of death was regressed on the proportion of two-stage
patients. Initial analyses were performed without risk-
adjustment, followed by adjustment by the individual
addition of one covariate at a time from the following list:
age, mean maximum aneurysm diameter, the proportion of
type II Crawford TAAA, the proportion of elective repairs,
and the proportion of patients with coronary artery disease
(CAD). Halves were added to zero counts when
computing log odds of death. The covariate effect associ-
ated with the proportion of two-stage patients is a log odds
ratio (OR), which describes the association between the
staging of the operation and death. These log ORs have
been converted to ORs for ease of interpretation, where an
OR of <1 indicates that death is less likely to occur in two-
stage patients. The presence of statistical heterogeneity was
assessed by the I2 statistic.
Analysis 2. The same technique for meta-regression
was applied as for analysis 1, but here, the four studies
that provided outcome data for each stage separately,
provided two outcomes in the meta-regression, whose
corresponding proportion of stage two operations are
0 and 1. This technique increases the power of the analysis
for comparing one-stage and two-stage repair at the
expense of ignoring the between-study correlation in the
data extracted from the four studies reporting results
stratiﬁed by operative staging.
Analysis 3. A random-effects meta-analysis was per-
formed, using the method of DerSimonian and Laird,5
using the log ORs from the four studies that provided
mortality rates by operation staging. The pooled effect is
the log OR describing the association between the staging
of the operation and death, which was converted to an OR.
The presence of statistical heterogeneity was assessed by
the I2 statistic.
Analysis 4. Individual patient data were used from the
St George’s Vascular Institute. A binary logistic regression
model was constructed to compare 30-day mortality in
one-stage and two-stage repair. Initially, no covariate
adjustment was made, but then adjustment was made for
age, sex, elective or emergency surgery, Crawford type II
aneurysms, and CAD. The covariate effects associated with
two-stage repair are log ORs that describe the association
between the staging of the operation and death, which
were converted to ORs.
RESULTS
The initial electronic search yielded 532 articles. After
screening of titles and abstracts, and additional searches
by hand in accordance with the inclusion criteria,
meta-analyses and metaregressions were performed using
data from 19 published studies3,6-22 after the addition of
new data from St George’s Vascular Institute to update
Fig 1. Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) ﬂowchart.
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vidual patient data was performed using data from the
updated St George’s Vascular Institute series only3
(Fig 1, Preferred Reporting Items for Systematic Reviews
and Meta-Analysis).
Study characteristics
Included were 19 studies (Table I) describing 660
patients who were a mean age of 64 to 71.3 years. The
30-day mortality ranged from 0% to 44.4%, with an overall
(across studies) rate of 12.6%. In-hospital mortality was
described rather than 30-day mortality for three
studies4,11,19 and was used to calculate 30-day mortality.
Speciﬁcally, all in-hospital deaths reported by Da Rocha
et al,4 van de Mortel et al,11 and Tshomba et al19 occurred
in the ﬁrst 30 days, such that in-hospital mortality was
equivalent to 30-day mortality. In this review, the propor-
tion of patients initially planned as a one-stage procedure,
but switched to a two-stage procedure because of hemody-
namic instability, was not reported in most of the studies.
After a mean follow-up of 26 months (range, 6-88.5
months) the overall mortality was 20.8%.
The treatment in 82.5% (544 of 660) of patients was
for a degenerative TAAA, 7.8% for dissection and resultant
TAAA, 2.4% for a visceral aortic patch aneurysm after open
repair, and 7.3% for disease attributable to other aortic
pathologies (ie, penetrating ulcers, intramural hematomas).
The extent of the TAAA by the Crawford classiﬁcation was
determined in 555 of 660 (84.1%) patients: 12.8%underwent repair for a type I, 26.2% for a type II, 37.2%
for a type III, 18.3% for a type IV, and 5.2% for type V.
Mean maximum aneurysm diameter ranged from 61 to
78 mm. Referral was for elective treatment in 589 patients
(89.2%), and 71 (10.8%) presented with symptomatic or
ruptured TAAA. Procedures were single-stage in 288 of
660 (43.6%) procedures and staged in 372 (56.4%). The
use of lumbar drains and the timing of paraplegia were
not used or were scarcely reported in most of the studies,
precluding any statistical comparison.
Analysis 1: Metaregression of aggregate-level data.
Analysis (Fig 2) failed to demonstrate a statistically signif-
icant association between the number of stages of the
procedure and death with evidence of heterogeneity
(unadjusted OR, 0.64; 95% conﬁdence interval [CI], 0.19-
2.16; P ¼ .45; I2 ¼ 0.42). There was also no statistically
signiﬁcant difference between single and staged procedures
after adjustment for age, aneurysm diameter, the propor-
tion of Crawford type II aneurysms, the proportion of
emergency cases, or the proportion of patients with CAD
(Table II).
Analysis 2: Metaregression including outcomes
stratiﬁed by operative staging. Four studies provided
mortality data stratiﬁed according to operative stage
(Tables III and IV; Fig 3).3,11,21,22 The metaregression
using these stratiﬁed outcome data did not demonstrate
a statistically signiﬁcant association between the number of
stages of the procedure and 30-day mortality (OR, 0.57;
95% CI, 0.24-1.36; P ¼ .19; I2 ¼ 0.38). There was also no
Table I. Study characteristics
First author Year No.
Mean
age, years Males, No.
Staged
procedure, No.
Emergent
procedure, No.
Procedural
success, %
Follow-up,
months
Fulton6 2005 10 70 8 2 0 96 22.1
Resch7 2006 13 64 5 11 2 100 79.2
Donas10 2007 8 72.8 6 0 1 89.6 13
Gawenda9 2007 6 e 5 0 0 100 23
Lee8 2007 17 69 13 17 0 100 27.3
van de Mortel11 2008 16 69 11 4 5 100 e
Da Rocha4 2009 9 71.5 40 4 0 97.2 12
Donas14 2009 58 74 45 58 9 100 16.6
Drinkwater13 2009 103 67 67 20 18 96.5 21
Quinones-Baldrich12 2009 17 68 11 5 1 100 30.5
Kabbani17 2010 36 e 16 33 3 100 23.9
Kuratani16 2010 86 71.6 62 75 10 92.5 26
Patel15 2010 29 71.7 7 26 6 94.1 28
Smith18 2011 24 76 10 0 0 100 88.5
Biasi3 (updated) 2012 51 72 27 37 3 100 22.6
Hughes22 2012 58 69 24 25 10 100 6
Lin21 2012 58 71.7 50 31 0 70.5 8
Markatis20 2012 9 72 8 9 0 100 8.7
Tshomba19 2012 52 71.3 39 15 1 100 11.7
Fig 2. Bubble plot shows 30-day mortality as a function of the
proportion of two-stage repairs in each study.
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procedures after sequential covariate risk adjustment for
age, aneurysm diameter, the proportion of Crawford type
II aneurysms, the proportion of emergency cases, or the
proportion of patients with CAD (Table V).
Analysis 3: A random-effects meta-analysis of single-
stage vs staged repair for TAAA. Four studies (187
patients) contributed to the random-effects meta-analysis
of single-stage vs staged repair of TAAA.3,12,21,22 Random-
effects meta-analysis using the four study-speciﬁc log ORs as
outcome data did not demonstrate a signiﬁcant association
between the number of stages of the procedure and death
(OR, 0.52; 95% CI, 0.15-1.72; P ¼ .28; I2 ¼ 0.37).Analysis 4: Logistic regression of individual patient
data. Data for 51 patients (26 males [53%]) contributed to
the analysis.3 The 30-day mortality was 16% (8 of 51). The
repair was single-stage in 14 patients and staged in 37.
Comorbidity was common: nine (17%) had a history of
CAD. Sixteen (31%) underwent surgery for Crawford type
II disease. Logistic regression demonstrated a statistically
signiﬁcant association between the number of stages of
the procedure and death (unadjusted OR, 0.16; 95% CI,
0.03-0.79; P ¼ .03). The relationship of staging with
mortality remained robust after adjustment for covariates
(adjusted OR, 0.04; 95% CI, 0.00-0.96; P < .05;
Table VI).
Descriptive analysis of secondary outcomes
Procedural success. The primary procedural success
(Table I), deﬁned as completed visceral debranching and
successful stent graft deployment, was 96.3% (range,
70.5%-100%). In three patients, the operation was not
completed because of perioperative instability. The proce-
dure in one patient was abandoned because of a restricted
ﬂow rate from the inﬂow vessel. Thirteen patients died of
perioperative-related complications. Six patients died of
aortic rupture while waiting for the second stage. Four
patients refused the second stage. Of the 660 patients for
whom both stages of the procedure were completed, 119
(18%) experienced an endoleak during the mean study
follow-up of 26.2 months (range, 6-88.5 months). Rein-
tervention was required in 28.
Adverse outcomes. The overall perioperative mortality
rate was 12.6% (range, 0%-44.4%; Table VII). A total of
139 patients died during the postoperative period. The
overall rate of permanent spinal cord ischemia was 3.4%
(range, 0%-15.3%). The overall rates of permanent renal
failure, mesenteric ischemia, and severe cardiopulmonary
Table II. Metaregression of aggregate-level data
Adjustment OR (95% CI) P I2a No.b
None 0.64 (0.19-2.16) .45 0.42 19
Age 0.62 (0.15-2.48) .47 0.49 17
TAAA diameter 0.69 (0.11-4.23) .66 0.52 16
Proportion of
Crawford type II TAAA 0.58 (0.14-2.41) .42 0.46 18
Elective patients 0.73 (0.14-3.73) .68 0.44 15
Patients with CAD 0.84 (0.15-4.60) .82 0.50 14
CAD, Coronary artery disease; CI, conﬁdence interval; OR, odds ratio; TAAA, thoracoabdominal aortic aneurysm.
aIndicating statistical heterogeneity.
bNumber of studies that contributed to the analysis.
Table III. Single- vs two-stage procedures: Study characteristics
First author Year No.
1 stage,
No.
2 stages,
No.
Mean age
Emergent
procedure
Mean operative time of
total procedure
1 stage,
years
2 stages,
years
1 stage,
No.
2 stages,
No.
1 stage,
minutes
2 stages,
minutes
Quinones-Baldrich12 2009 20 14 6 62 62 1 0 510 498
Biasi3 (updated) 2012 51 14 37 68 68 3 0 e e
Hughes22 2012 58 33 25 69.9 69.9 4 6 373 301
Lin21 2012 58 27 31 75 75 0 0 402 465
Table IV. Single vs two-stage procedures: Perioperative results
First author
30-day
mortality
Irreversible spinal
cord ischemia
Renal failure
requiring dialysis
Mesenteric
ischemia
Major pulmonary and
cardiac complications
1 stage 2 stages 1 stage 2 stages 1 stage 2 stages 1 stage 2 stages 1 stage 2 stages
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Quinones-Baldrich12 0 (0) 0 (0) 1 (7.1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (14.2) 0 (0)
Biasi3 updated 5 (35.7) 3 (8.1) 1 (7.1) 1 (2.7) 0 (0) 5 (13.5) 4 (28.5) 2 (14.2) 1 (7.1) 4 (10.8)
Hughes22 4 (12.1) 1 (4) 2 (6) 0 (0) 5 (15.5) 2 (8) 0 (0) 0 (0) 6 (18.1) 2 (8)
Lin21 6 (22.2) 8 (25.8) e e 4 (14.8) 2 (6.4) 2 (7.4) 3 (9.6) 4 (14.8) 4 (12.9)
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4.6% (range, 0%-20.8%), and 7.8% (range, 0%-17.6%).
Graft patency. The overall rate of visceral graft
patency (Table VIII) during the mean follow-up of
26.2 months (range, 6-88.5 months) was 94.7%. Eighty-
one grafts were occluded: six to the celiac trunk, 27 to the
superior mesenteric artery, and 48 to the renal arteries.
DISCUSSION
The present study suggests that lower perioperative
mortality may be associated with a two-stage hybrid repair
of TAAA than with a single-stage procedure, but conclusive
evidence is lacking. Meta-analysis and metaregression
provided ORs that supported this assertion, but the
P values obtained were not statistically signiﬁcant. This
apparent lack of powermight be explained by several factors.Several studies reported the outcome of hybrid TAAA
repair, and the existing evidence comprises mostly single-
center reports with small sample sizes. Data stratiﬁed
according to surgical staging, which would be especially
valuable and militate against an over-reliance on
aggregate-level data, were rarely provided. There were
important heterogeneities between studies in operative
approach and in reporting criteria for key outcomes.
However, the results of the logistic regression model,
constructed using individual patient data from one
center, demonstrated that a staged procedure was safer
(unadjusted analysis, P ¼ .03; adjusted analysis, P < .05),
and ORs from pooled analyses supported this ﬁnding,
despite lacking statistical signiﬁcance. The main conclusion
must be that the current data are insufﬁcient to support
a uniform recommendation to perform either a single or
Fig 3. Forest plot shows 30-day mortality of single-stage vs two-stage stage repair in studies for which comparative
data were available. CI, Conﬁdence interval.
Table V. Metaregression including outcomes stratiﬁed
by operative staging
Adjustment OR (95% CI) P I2a No.b
None 0.57 (0.24-1.36) .19 0.38 23
Age 0.53 (0.21-1.32) .16 0.40 21
TAAA diameter 0.52 (0.18-1.57) .23 0.46 20
Proportion of
Crawford type II
TAAA
0.53 (0.21-1.37) .18 0.41 22
Elective patients 0.59 (0.20-1.73) .31 0.41 19
Patients with CAD 0.57 (0.18-1.88) .33 0.48 16
CAD, Coronary artery disease; CI, conﬁdence interval; OR, odds ratio;
TAAA, thoracoabdominal aortic aneurysm.
aIndicating statistical heterogeneity.
bNumber of outcomes that contribute to the analysis (four studies stratiﬁed
by operative staging).
Table VI. Logistic regression of individual patient data13
Adjustment OR (95% CI) P
None 0.16 (0.03-0.79) .03
All 0.04 (0.00-0.96) .05
CI, Conﬁdence interval; OR, odds ratio.
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reported distinct results of one-stage and two-stage hybrid
repair.
More data (ideally randomized but more realistically in
the form of prospective, multicenter registries) are required
to deﬁne the appropriate role of hybrid repair in the
management of TAAA. In 2012, Moulakakis et al23 re-
ported a meta-analysis that assessed the safety and efﬁcacy
of hybrid repair for TAAA. They analyzed 19 publications
with a total of 507 patients and concluded that hybrid
repair of TAAA in poor surgical candidates was still associ-
ated with signiﬁcant morbidity and mortality. However,their study did not consider the potential differences
in outcome between one-stage and two-stage repair or
between emergency and elective surgery.
Open repair of TAAA has traditionally been accompa-
nied by signiﬁcant morbidity and mortality. The use of
adjuncts, such as distal aortic perfusion and cerebrospinal
ﬂuid drainage, has decreased the rates of permanent
paraplegia or kidney failure requiring dialysis to <5% and
30-day mortality <10% when open TAAA repair is per-
formed in high-volume centers.24,25 However, when this
operation is performed across a broad spectrum of institu-
tions, the overall morbidity and mortality can be signiﬁ-
cantly higher. One statewide registry reported a 1-year
mortality rate of 31% after open TAAA repair.26 Further-
more, many patients are considered unﬁt for open repair.
The 660 patients reviewed in the present meta-analysis of
hybrid TAAA repair had an overall 30-day mortality of
12.6% (range, 0%-44.4%). The heterogeneity of the
morbidity and mortality at different centers raises debate
about the role and beneﬁts of the technique and is reﬂected
in the large I2 statistics accompanying the metaregressions
Table VII. Perioperative results
First author
30-day
mortality, %
Irreversible spinal
cord ischemia, %
Renal failure
requiring dialysis, %
Major pulmonary and
cardiac complications, %
Mesenteric
ischemia, %
Fulton6 0 0 0 10 0
Resch7 23 15.3 15.3 15.3 7.6
Donas10 12.5 0 12.5 50 0
Gawenda9 0 0 0 16.6 0
Lee8 23.5 0 16.6 17.6 0
van de Mortel11 25 0 18.7 6.2 25
Da Rocha4 44.4 11.1 11.1 0 11.1
Donas14 8.6 3.4 0 3.4 0
Drinkwater13 14.9 8.6 27.1 4.8 2.9
Quinones-Baldrich12 0 5.8 0 11.7 0
Kabbani17 8.3 0 11.1 8.3 8.3
Kuratani16 2.3 0 2.3 0 3.4
Patel15 3.4 3.4 17.2 3.4 3.4
Smith18 12.5 8.3 16.6 8.3 20.8
Biasi3 (updated) 23.5 3.9 9.8 9.8 11.7
Hughes22 8.6 3.4 12 13.7 0
Lin21 24.1 e 10.3 13.7 5.1
Markatis20 0 0 0 0 0
Tshomba19 13.4 1.9 0 7.7 1.9
Table VIII. Postoperative results
First author
Follow-up,
months No.
Overall
mortality, %
Endoleak,
%
Endoleak requiring
reintervention, %
Graft
thrombosis, %
Fulton6 22.1 10 0 10 10 e
Resch7 79.2 13 46.1 61.5 23 4.6
Donas10 13 8 12.5 0 0 8.3
Gawenda9 23 6 0 16.6 16.6 0
Lee8 27.3 17 23.5 11.7 5.9 7.2
van de Mortel11 e 16 31.2 12.5 0 1.4
Da Rocha4 12 9 44.4 0 e 7.3
Donas14 16.6 58 25.8 15.5 10.3 6.5
Drinkwater13 21 103 15.5 32 e 5
Quinones-Baldrich12 30.5 17 29.4 23.5 11.7 0
Kabbani17 23.9 36 16.6 44.4 5.5 3.5
Kuratani16 26 86 4.6 10.4 3.4 13.08
Patel15 28 29 3.4 34.4 6.9 15.5
Smith18 88.5 24 12.5 8.3 8.3 15.1
Biasi3 (updated) 22.6 51 41.1 23.5 3.9 3.5
Hughes22 6 58 8.6 3.4 3.4 10
Lin21 8 58 41.3 3.4 0 3.5
Markatis20 8.7 9 0 11.1 0 4.5
Tshomba19 11.7 52 36.5 9.6 1.9 0
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for the disparate results between institutions, including
patient selection (some series with low mortality predomi-
nantly studied pararenal or type IV,10,12 whereas other
series with high mortality included only type I, II, and
III TAAAs9,14), patient age and comorbidities, and the
learning curve of hybrid repair.
Some authors1 encourage the use of hybrid TAAA
repair rather than conventional surgery in the ﬁttest
surgical patients. This may be due to the potential peri-
operative protective effect of hybrid treatment from typical
complications of open TAAA repair such as bleedingdisorder, respiratory complications, and cardiac or renal
failure. Renal visceral debranching is by far the most
invasive part of the hybrid procedure. Bypass grafting via
laparotomy requires extensive intra-abdominal dissection,
which can take several hours and lead to signiﬁcant
physiologic impairment, especially in high-risk patients.
Supporters of the single-stage approach cite that it elimi-
nates the risk of rupture between stages13,21 and failure
to treat the aneurysm due to patient withdrawal of consent
for the endovascular stage. Single-stage surgery minimizes
access site-related complications because a conduit can be
used directly on the aorta or iliac vessels. There is a strong
JOURNAL OF VASCULAR SURGERY
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recently symptomatic aneurysms who are stable
intraoperatively.
The multistage approach offers the advantage of
shortening the maximum procedural time, thus reducing
trauma, ischemic time, and the risk of renal injury.
Paraplegia after TAAA repair may relate to ﬂuctuations in
postoperative hemodynamics. Therefore, a hypotensive
and coagulopathic patient who has undergone extensive
intra-abdominal dissection and signiﬁcant cardiovascular
instability should not immediately undergo stent grafting
to decrease the risk of paraplegia.
The hybrid approach does not eliminate complications
related to an extensive TAAA involving visceral artery
repair. The risk of postoperative renal failure remains
considerable. The overall rate of postoperative renal failure
requiring dialysis was 10% in this study. The data did not
allow further exploration of whether this was due to pre-
existing renal disease, to a detrimental effect of warm
ischemic time during the period of renal debranching, to
the nephrotoxicity of intravenous contrast administration,
or to a combination of these factors. The overall rate
of visceral graft patency during follow-up was 94.7%.
However, difference in outcomes in case of renal or mesen-
teric graft thrombosis must be stressed. Renal branch
occlusion may be of little clinical signiﬁcance because
most patients have two kidneys, but superior mesenteric
artery occlusion is often fatal.
Spinal cord injury, due to diminished spinal cord perfu-
sion as a consequence of sacriﬁce of multiple thoracic
intercostal arteries, remains one of the most feared compli-
cations of TAAA repair. Bischoff et al27 used an animal
model to investigate the link between the number of stages
during hybrid TAAA repair and the risk of spinal cord
ischemia. Their research suggested that a staged approach
prevented spinal cord injury. The overall rate for spinal
cord ischemia in this study was 6.5%, with irreversible para-
plegia in 3.4% of the patients. This rate is comparable to
series reporting the most favorable results after open repair
of TAAA.24,25
Comparison between published series addressing the
outcomes of TAAA repair remains hazardous for a number
of reasons. Several studies reporting results of open, hybrid,
or total endovascular repair of TAAA did not classify the
extent of aneurysmal lesions, resulting in considerable
heterogeneity. Furthermore, there is an important lack of
homogeneity of patients treated. Most of the hybrid series
report results of patients deemed unsuitable for open repair
and who undergo repair with fenestrated and branched
stent graftsdreﬂecting outcomes in patients anatomically
suitable for endovascular treatmentdwithout reporting
the turndown rates. Two studies compared hybrid TAAA
repair with patients who underwent open TAAA repair,
and the results reported were discordant. The Ann Arbor
team15 concluded that open TAAA repair was a signiﬁcant
factor of early mortality and morbidity (P ¼ .021).
However, the Boston team28 reported that hybrid TAAA
repair in high-risk patients had signiﬁcant morbidity andmortality and advocated a noninterventional approach in
many such patients.
Statistical limitations apply to the present study.
Perhaps the most important limitation is that patients
were not randomized to receive one-stage or two-stage
operations in any of the included studies, and hence it is,
at best, extremely difﬁcult to establish causation. This
lack of randomization provides the motivation to adjust
for potential confounders, which we have performed in
our metaregressions and logistic regressions, as far as the
data will allow. Metaregression techniques are also based
on normal approximations, which lack accuracy for small
studies with rare events, such as some of ours, uncertainty
in the estimates is often understated, and the technique
used is further compromised because it requires estimating
the between-study variance from relatively few studies.29
More sophisticated methods have also been reported for
combining individual patient data and aggregate level
data in the same analysis.30,31 This was not attempted in
the present study because of the paucity of data available
and the poor quality of most reports.
Finally, the long-term durability of hybrid endograft
procedures needs to be determined. In this report, endo-
leak developed in 119 of 660 patients (18%), with 23.5%
of these endoleaks requiring a reintervention. The effect
of these reinterventions on freedom from aneurysm-
related mortality needs to be assessed.
As an alternative to hybrid or openTAAA repair, a totally
endovascular approach using multibranched endografts
may be less invasive and has the potential to reduce operative
risks in patients with TAAA.32 New models of branched
endografts have become available, and results are promising.
However, the technique remains largely investigational,
and a learning curve should be expected. Furthermore,
full endovascular repair can be applied only in selected
patients. Anatomic limitations (aortic morphology and
access considerations) must be taken into account as well
as the quality of the targeted side branches. Furthermore,
technical expertise with endovascular grafting, as well as
visceral vessel cannulation and stenting, are required. Long
radiation exposure to both patients and operators are other
important factors to consider. Furthermore, the inherent
delay in manufacturing limits the applicability of multi-
branched endovascular repair in emergent cases.CONCLUSIONS
Hybrid repair of TAAA may reduce early morbidity
and mortality even in a group considered high risk for
open surgery but still carries non-negligible risks of peri-
operative complications. Perioperative mortality, spinal
cord ischemia, and renal failure have decreased with center
volume and may be limited in patients undergoing a staged
procedure.
The results of this study demonstrated a lower mortality
after a staged procedure but without providing statistically
signiﬁcant evidence. The available literature consists of
small case series or retrospective studies with considerable
JOURNAL OF VASCULAR SURGERY
1200 Canaud et al November 2013heterogeneity. Prospective data are still needed to investi-
gate whether a single or staged procedure should be favored.
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